Bacterial, mycobacterial, and protozoal infections after liver transplantation - Part I

Liver Transplantation

Volumn 11, Issue 12, 2005, Pages 1452-1459

  Blair, James E ^a   Kusne, Shimon ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METICILLIN; PENTAMIDINE ISETHIONATE; PRIMAQUINE; PSEUDOMONIC ACID; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; SULFADIAZINE; TRIMETREXATE; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG ANTAGONISM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; LIVER TOXICITY; LIVER TRANSPLANTATION; MYCOBACTERIOSIS; PNEUMOCYSTOSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; SURGICAL INFECTION; TOXOPLASMOSIS; VIRUS INFECTION;

BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MYCOBACTERIUM INFECTIONS; POSTOPERATIVE COMPLICATIONS; PROTOZOAN INFECTIONS; SURVIVAL RATE; WORLD HEALTH;

EID: 30444451186     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20624     Document Type: Article

References (82)

1. Rubin RH. The direct and indirect effects of infection in liver transplantation: Pathogenesis, impact, and clinical management. Curr Clin Top Infect Dis 2002;22:125-154.
2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751.
3. Barkholt L, Ericzon BG, Tollemar J, Malmborg AS, Ehrnst A, Wilczek H, et al. Infections in human liver recipients: Different patterns early and late after transplantation. Transpl Int 1993;6: 77-84.
4. Snydman DR. Infection in solid organ transplantation. Transpl Infect Dis 1999;1:21-28.
5. Lumbreras C, Lizasoain M, Moreno E, Aguado JM, Gomez R, Garcia I, et al. Major bacterial infections following liver transplantation: A prospective study. Hepatogastroenterology 1992; 39:362-365.
6. Dominguez EA. Long-term infectious complications of liver transplantation. Semin Liver Dis 1995;15:133-138.
7. Raakow R, Bechstein WO, Kling N, John K, Knoop M, Keck H, et al. The importance of late infections for the long-term outcome after liver transplantation. Transpl Int 1996;9(Suppl 1):S155-156.
8. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation: An analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67:132-143.
9. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, et al. Bacterial infection as a complication of liver transplantation: Epidemiology and risk factors. Rev Infect Dis 1991;13:387-396.
10. Paya CV, Hermans PE. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis 1989;8:499-504.
11. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology 1995; 21:1328-1336.
12. Mor E, Cohen J, Erez E, Grozovsky A, Shaharabani E, Bar-Nathan N, et al. Short intensive care unit stay reduces septic complications and improves outcome after liver transplantation. Transplant Proc 2001;33:2939-2940.
13. Itoh K, Hashimoto T, Shimizu Y, Otobe Y, Tanaka M, Nakamura Y, et al. Bacterial and fungal infections after living related donor liver transplantation. Transplant Proc 1996;28:2404-2405.
14. Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996;22:997-1003.
15. Emre S, Sebastian A, Chodoff L, Boccagni P, Meyers B, Sheiner PA, et al. Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med 1999;66:310-313.
16. Hjortrup A, Rasmussen A, Hansen BA, Hoiby N, Heslet L, Moesgaard F, et al. Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination. Transplant Proc 1997;29:3106-3110.
17. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002;73:1904-1909.
18. Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, et al. Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients. Crit Care Med 2002;30:1204-1209.
19. Maring JK, Zwaveling JH, Klompmaker IJ, van der Meer J, Slooff MJ. Selective bowel decontamination in elective liver transplantation: No improvement in endotoxaemia, initial graft function and post-operative morbidity. Transpl Int 2002;15: 329-334. Epub 2002 Jun 13.
20. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002;74:123-127.
21. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000;6:54-61.
22. Wagener MM, Yu VL. Bacteremia in transplant recipients: A prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992;20:239-247.
23. McClean K, Kneteman N, Taylor G. Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994;15:582-584.
24. Torre-Cisneros J, Herrero C, Canas E, Reguera JM, De La Mata M, Gomez-Bravo MA. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002;21:385-388. Epub 2002 May 8.
25. Falagas ME, Snydman DR, Griffith J, Werner BG, Boston Center for Liver Transplantation CMVIG Study Group. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 1996;23:468-474.
26. Hollenbeak CS, Alfrey EJ, Sheridan K, Burger TL, Dillon PW. Surgical site infections following pediatric liver transplantation: Risks and costs. Transpl Infect Dis 2003;5:72-78.
27. Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001;130:388-395.
28. Arnow PM, Zachary KC, Thistlethwaite JR, Thompson KD, Bova JL, Newell KA. Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation 1998;65:1500-1503.
29. Gunsar F, Rolando N, Pastacaldi S, Patch D, Raimondo ML, Davidson B, et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 2003;9:605-611.
30. Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: A review of nonsurgical causes. Liver Transpl 2001;7:75-81.
31. Rabkin JM, Orloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, et al. Hepatic allograft abscess with hepatic arterial thrombosis. Am J Surg 1998;175:354-359.
32. Tachopoulou OA, Vogt DP, Henderson JM, Baker M, Keys TF. Hepatic abscess after liver transplantation: 1990-2000. Transplantation 2003;75:79-83.
33. Jacobs F, Van de Stadt J, Gelin M, Nonhoff C, Gay F, Adler M, et al. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery 1992;111:98-100.
34. Vogel U, Luneberg E, Kuse ER, Neulinger AL, Frosch M. Extragenital Mycoplasma hominis infection in two liver transplant recipients. Clin Infect Dis 1997;24:512-513.
35. Pla MP, Berenguer J, Arzuaga JA, Banares R, Polo JR, Bouza E. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn Microbiol Infect Dis 1992;15:703-706.
36. Knechtle SJ, Babalola JA, D'Alessandro AM, Pirsch JD, Kalayoglu M. Clostridial infection of a liver transplant treated with retransplantation. Clin Transplant 1997;11:206-208.
37. Golfieri R, Giampalma E, Morselli Labate AM, d'Arienzo P, Jovine E, Grazi GL, et al. Pulmonary complications of liver transplantation: Radiological appearance and statistical evaluation of risk factors in 300 cases. Eur Radiol 2000;10:1169-1183.
38. Singh N, Gayowski T, Wagener MM, Marino IR. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation 1999;67:1138-1144.
39. Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Pulmonary infections in liver transplant recipients receiving tacrolimus: Changing pattern of microbial etiologies. Transplantation 1996; 61:396-401.
40. Torres A, Ewig S, Insausti J, Guergue JM, Xaubet A, Mas A, et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest 2000;117: 494-502.
41. Duran FG, Piqueras B, Romero M, Carneros JA, de Diego A, Salcedo M, et al. Pulmonary complications following orthotopic liver transplant. Transpl Int 1998;11 (Suppl 1):S255-S259.
42. Neumann UP, Langrehr JM, Kaisers U, Lang M, Schmitz V, Neuhaus P. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int 2002;15:226-232. Epub 2002 Apr 6.
43. Afessa B, Gay PC, Plevak DJ, Swensen SJ, Patel HG, Krowka MJ. Pulmonary complications of orthotopic liver transplantation. Mayo Clin Proc 1993;68:427-434.
44. Allen KA, Markin RS, Rennard SI, Shaw BW Jr, Thompson AB, Wood RP, et al. Bronchoalveolar lavage in liver transplant patients. Acta Cytol 1989;33:539-543.
45. Johnson PC, Hogg KM, Sarosi GA. The rapid diagnosis of pulmonary infections in solid organ transplant recipients. Semin Respir Infect 1990;5:2-9.
46. DeAngelo AJ, Ouellette D. Bronchiolitis obliterans organizing pneumonia in an orthotopic liver transplant patient. Transplantation 2002;73:544-546.
47. Del Bono L, Filipponi F, Marchetti G, Ferranti S, Menichetti F, Mosca F. A 59-year-old liver-transplanted woman with fever, dyspnea and pulmonary infiltrates. Clin Microbiol Infect 2003; 9:1057-1061.
48. Kleindienst R, Fend F, Prior C, Margreiter R, Vogel W. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus. Clin Transplant 1999;13:65-67.
49. Kohli-Seth R, Killu C, Amolat MJ, Oropello J, Manasia A, Leibowitz A, et al. Bronchiolitis obliterans organizing pneumonia after orthotopic liver transplantation. Liver Transpl 2004;10: 456-459.
50. Prodinger WM, Bonatti H, Allerberger F, Wewalka G, Harrison TG, Aichberger C, et al. Legionella pneumonia in transplant recipients: A cluster of cases of eight years' duration. J Hosp Infect 1994;26:191-202.
51. Ernst A, Gordon FD, Hayek J, Silvestri RC, Koziel H. Lung abscess complicating Legionella micdadei pneumonia in an adult liver transplant recipient: Case report and review. Transplantation 1998;65:130-134.
52. Tkatch LS, Kusne S, Irish WD, Krystofiak S, Wing E. Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin Infect Dis 1998;27:1479-1486.
53. Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998;65:1169-1172.
54. Singh N, Paterson DL, Chang FY, Gayowski T, Squier C, Wagener MM, et al. Methicillin-resistant Staphylococcus aureus: The other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000;30:322-327.
55. Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM, Stout J, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002;23: 495-501.
56. Bert F, Galdbart JO, Zarrouk V, Le Mee J, Durand F, Mentre F, et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 2000; 31:1295-1299.
57. Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003;9:754-759.
58. Paterson DL, Rihs JD, Squier C, Gayowski T, Sagnimeni A, Singh N. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 2003;75:194-198.
59. Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996;61:1192-1197.
60. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-670.
61. Bakir M, Bova JL, Newell KA, Millis JM, Buell JF, Arnow PM. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation 2001; 72:1032-1037.
62. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am J Transplant 2003;3: 902-905.
63. Dominguez EA, Davis JC, Langnas AN, Winfield B, Cavalieri SJ, Rupp ME. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients. Liver Transpl Surg 1997; 3:586-590.
64. Newell KA, Millis JM, Arnow PM, Bruce DS, Woodle ES, Cronin DC, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998;65:439-442.
65. Orloff SL, Busch AM, Olyaei AJ, Corless CL, Benner KG, Flora KD, et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999;177:418-422.
66. Papanicolaou GA, Meyers BR, Meyers J, Mendelson MH, Lou W, Emre S. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality. Clin Infect Dis 1996;23:760-766.
67. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: Attributable costs and outcomes. Intensive Care Med 2002;28:692-697. Epub 2002 Apr 12.
68. Patel R, Allen SL, Manahan JM, Wright AJ, Krom RA, Wiesner RH, et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001;7:27-31.
69. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001;7:22-26. Erratum in: Liver Transpl 2001;7:471.
70. Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001;33:126-128. Epub 2001 May 23.
71. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Rufi G, et al. Spanish Transplantation Infection Study Group, GESITRA. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997;63:1278-1286. Erratum in: Transplantation 1997;64:942.
72. Singh N, Wagener MM, Gayowski T. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002;74:892-895.
73. Graham JC, Kearns AM, Magee JG, El-Sheikh MF, Hudson M, Manas D, et al. Tuberculosis transmitted through transplantation. J Infect 2001;43:251-254.
74. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998;27:1266-1277.
75. Henderson C, Meyers B, Humayun Gultekin S, Liu B, Zhang DY. Intracranial tuberculoma in a liver transplant patient: First reported case and review of the literature. Am J Transplant 2003; 3:88-93.
76. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al., American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
77. Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004;38:1428-1439. Epub 2004 Apr 30.
78. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis 1995;21:1077-1089.
79. Simon DM, Levin S. Infectious complications of solid organ transplantations. Infect Dis Clin North Am 2001;15:521-549.
80. Rodriguez M, Sifri CD, Fishman JA. Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients. Clin Infect Dis 2004;38:e76-78. Epub 2004 Mar 29.
81. Barcan LA, Dallurzo ML, Clara LO, Valledor A, Macias S, Zorkin E, et al. Toxoplasma gondii pneumonia in liver transplantation: Survival after a severe case of reactivation. Transpl Infect Dis 2002;4:93-96.
82. Singh N, Gayowski T, Marino IR. Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996;2:299-300.